INTELLIGENCE IN ACTION

Changing the Script on the Opioid Crisis

January 13, 2020

“I entered the pharmacist profession because I care about people,” says Rodrick Marriott, Connecticut’s Director of Drug Control. “And I left it because I felt I needed to find a different way to do it. And I think I found my way. And I’m really lucky to be here.”

In a recent video interview, Marriott discusses how he and his team are helping the people of Connecticut get the care they need, while also battling an opioid epidemic that has devastated communities across the state. It’s clearly not just a job for Marriott.


Connecticut has been particularly hard hit by the crisis, with a high rate of drug-related deaths across a relatively small state population. Since their Electronic Prescribing for Controlled Substances (EPCS) requirement took effect in 2018, overdose ER admissions dipped and opioid-related deaths have plateaued. Marriott, who is also a pharmacist, was instrumental in creating an effective law that garnered wide buy in from the medical community. In the video, he talks about why the state pushed for an EPCS requirement and offers lessons learned so that other states can successfully implement an EPCS requirement, too.

Earlier this month, Arizona, Iowa, North Carolina, Oklahoma and Rhode Island began to require some form of e-prescribing, which includes EPCS. Many more states are expected to follow suit in advance of the federal mandate, outlined in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, which requires all Medicare Part D covered controlled substance prescriptions be transmitted electronically by 2021. 

“At the end of the day, we’re here for patient care. We want to make sure our patients are protected and safe, but also getting the medications they need,” says Marriott.

For more of Marriott’s story and Connecticut’s success, watch the video. And to learn more about how health information technology can help change the script on the opioid crisis, visit Intelligence in Action. 

Related Articles

October 19, 2020

Surescripts Warns CMS That Delaying EPCS Mandate Puts Seniors at Risk of COVID-19 and Undermines Efforts to Address the Opioid Crisis

In our response to CMS’s proposal, we argue that such a delay will put seniors at risk of COVID-19 exposure and undermine efforts to address the nation’s growing opioid crisis.

Read more...
September 15, 2020

The Opioid Crisis Is Still with Us

Mental health experts and the recovery community have been sounding the alarm for months now. But there are things that the healthcare industry is doing—and can continue to embrace—that are of real help in combatting the crisis. 

Read more...
July 16, 2020

Revisiting a Groundbreaking Prescribing Regulation

More than a decade ago, the U.S. Drug Enforcement Administration (DEA) published its Electronic Prescribing for Controlled Substances (EPCS) Interim Final Rule (IFR). Surescripts applauded this regulation, which took effect on June 1, 2010. 

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX